Metronidazole

"Metronidazole" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

A nitroimidazole used to treat AMEBIASIS; VAGINITIS; TRICHOMONAS INFECTIONS; GIARDIASIS; ANAEROBIC BACTERIA; and TREPONEMAL INFECTIONS. It has also been proposed as a radiation sensitizer for hypoxic cells. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985, p133), this substance may reasonably be anticipated to be a carcinogen (Merck, 11th ed).

Descriptor ID	D008795
MeSH Number(s)	D02.640.672.500 D03.383.129.308.658.500
Concept/Terms	Metronidazole Metronidazole 2-Methyl-5-nitroimidazole-1-ethanol 2 Methyl 5 nitroimidazole 1 ethanol Trichazol Trichazol Trichopol Trichopol Trivazol Trivazol Vagilen Vagilen Bayer 5360 Bayer 5360 Clont Clont Danizol Danizol Flagyl Flagyl Gineflavir Gineflavir Metric Metric Metrodzhil Metrodzhil MetroGel MetroGel Metrogyl Metrogyl Metronidazole Hydrochloride Metronidazole Hydrochloride Hydrochloride, Metronidazole Metronidazole Monohydrochloride Monohydrochloride, Metronidazole Metronidazole Phosphate Metronidazole Phosphate Phosphate, Metronidazole Metronidazole Phosphoester Phosphoester, Metronidazole Satric Satric

Below are MeSH descriptors whose meaning is more general than "Metronidazole".

Chemicals and Drugs [D]
Organic Chemicals [D02]
Nitro Compounds [D02.640]
Nitroimidazoles [D02.640.672]
Metronidazole [D02.640.672.500]
Heterocyclic Compounds [D03]
Heterocyclic Compounds, 1-Ring [D03.383]
Azoles [D03.383.129]
Imidazoles [D03.383.129.308]
Nitroimidazoles [D03.383.129.308.658]
Metronidazole [D03.383.129.308.658.500]

Below are MeSH descriptors whose meaning is related to "Metronidazole".

Below are MeSH descriptors whose meaning is more specific than "Metronidazole".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Metronidazole" by people in this website by year, and whether "Metronidazole" was a major or minor topic of these publications.

Bar chart showing 19 publications over 13 distinct years, with a maximum of 2 publications in 1996 and 1999 and 2006 and 2013 and 2019 and 2021

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1996	1	1	2
1999	2	0	2
2001	1	0	1
2002	0	1	1
2003	0	1	1
2006	1	1	2
2008	0	1	1
2013	0	2	2
2014	1	0	1
2017	1	0	1
2019	1	1	2
2021	1	1	2
2022	0	1	1

Below are the most recent publications written about "Metronidazole" by people in Profiles.

Kissinger PJ, Gaydos CA, Seña AC, Scott McClelland R, Soper D, Secor WE, Legendre D, Workowski KA, Muzny CA. Diagnosis and Management of Trichomonas vaginalis: Summary of Evidence Reviewed for the 2021 Centers for Disease Control and Prevention Sexually Transmitted Infections Treatment Guidelines. Clin Infect Dis. 2022 04 13; 74(Suppl_2):S152-S161.

View in: PubMed
Muzny CA, Schwebke JR, Nyirjesy P, Kaufman G, Mena LA, Lazenby GB, Van Gerwen OT, Graves KJ, Arbuckle J, Carter BA, McMahon CP, Eder S, Shaw J, Pandey B, Chavoustie SE. Efficacy and Safety of Single Oral Dosing of Secnidazole for Trichomoniasis in Women: Results of a Phase 3, Randomized, Double-Blind, Placebo-Controlled, Delayed-Treatment Study. Clin Infect Dis. 2021 09 15; 73(6):e1282-e1289.

View in: PubMed
Markwei MT, Babatunde I, Rathi N, Fan C, Prah MA, Joo J, Hackett L, Soper DE, Goje O. Preincision adjunctive prophylaxis for cesarean deliveries a systematic review and meta-analysis. Am J Obstet Gynecol. 2021 10; 225(4):382.e1-382.e13.

View in: PubMed
Mohammed AD, Khan MAW, Chatzistamou I, Chamseddine D, Williams-Kang K, Perry M, Enos R, Murphy A, Gomez G, Aladhami A, Oskeritzian CA, Jolly A, Chang Y, He S, Pan Z, Kubinak JL. Gut Antibody Deficiency in a Mouse Model of CVID Results in Spontaneous Development of a Gluten-Sensitive Enteropathy. Front Immunol. 2019; 10:2484.

View in: PubMed
Lazenby GB, Thompson L, Powell AM, Soper DE. Unexpected High Rates of Persistent Trichomonas vaginalis Infection in a Retrospective Cohort of Treated Pregnant Women. Sex Transm Dis. 2019 01; 46(1):2-8.

View in: PubMed
Cowdell JC, Burton MC, Harris D, Holmes-Maybank K, Harte BJ, Josephson SA. Rendered Speechless. J Hosp Med. 2017 05; 12(5):352-355.

View in: PubMed
Lazenby GB, Unal ER, Andrews AL, Simpson K. Cost-effectiveness analysis of annual Trichomonas vaginalis screening and treatment in HIV-positive women to prevent HIV transmission. Sex Transm Dis. 2014 Jun; 41(6):353-8.

View in: PubMed
Marsh JW, Curry SR. Therapeutic approaches for Clostridium difficile infections. Curr Protoc Microbiol. 2013 Oct 02; 30:9A.3.1-9A.3.9.

View in: PubMed
Surawicz CM, Brandt LJ, Binion DG, Ananthakrishnan AN, Curry SR, Gilligan PH, McFarland LV, Mellow M, Zuckerbraun BS. Guidelines for diagnosis, treatment, and prevention of Clostridium difficile infections. Am J Gastroenterol. 2013 Apr; 108(4):478-98; quiz 499.

View in: PubMed
Scheurer D. Diagnostic and treatment delays in recurrent Clostridium difficile-associated disease. J Hosp Med. 2008 Mar; 3(2):156-9.

View in: PubMed

People

Explore

Similar Concepts

Top Journals